title: Serum immunoglobulin G antibodies to the GOR autoepitope are present in patients with occult hepatitis C virus (HCV) infection despite lack of HCV-specific antibodies.
abstract: Antibody responses to the GOR autoepitope are frequently detected among anti-hepatitis C virus (anti-HCV)-positive patients with chronic hepatitis. Sera from 110 anti-HCV-negative patients with occult HCV infection, as diagnosed by detection of HCV RNA in hepatic tissue, were investigated for GOR antibody reactivity. A positive test for anti-GOR immunoglobulin G (IgG) was found for 22 (20%) of them. The frequency and titers of anti-GOR IgG were significantly lower than those in chronic hepatitis C patients (70/110, 63.6%; P < 0.001). Anti-GOR IgG was not detected in any of the 120 patients with HCV-unrelated liver disease. The anti-GOR IgG assay showed specificity and sensitivity values of 100% and 20%, respectively, among the sera from patients with occult HCV infection; the positive and negative predictive values were 100% and 44.3%, respectively. None of the clinical, laboratory, or histological characteristics of the patients with occult HCV infection were different according to GOR antibody status, except that the percentage of HCV RNA-positive hepatocytes was significantly greater (P = 0.042) in patients with occult HCV infection who tested positive for anti-GOR IgG. In conclusion, serum anti-GOR IgG is present in patients with occult HCV infection, despite a lack of detectable HCV-specific antibodies as determined by commercial tests. Testing for anti-GOR IgG in patients in whom HCV RNA is not detected in their sera may help with the identification of a subset of patients with occult HCV infection without the need to perform a liver biopsy.
authors: Fundación para el Estudio de las Hepatitis Virales, Guzmán el Bueno, 72, 28015 Madrid, Spain.
authors: Juan A
authors: JA
authors: Quiroga
authors: Inmaculada
authors: I
authors: Castillo
authors: Javier
authors: J
authors: Bartolomé
authors: Vicente
authors: V
authors: Carreño
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D000914:Antibodies, Viral / Q000096:biosynthesis* / Q000097:blood; D000918:Antibody Specificity; D000941:Antigens / Q000235:genetics / Q000276:immunology*; D001323:Autoantibodies / Q000096:biosynthesis* / Q000097:blood; D001324:Autoantigens / Q000276:immunology*; D000939:Epitopes / Q000235:genetics / Q000276:immunology*; D005260:Female; D016174:Hepacivirus / Q000276:immunology*; D019698:Hepatitis C, Chronic / Q000097:blood / Q000201:enzymology / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000096:biosynthesis* / Q000097:blood; D008297:Male; D008875:Middle Aged; D008969:Molecular Sequence Data
chemical_list: D000914:Antibodies, Viral; D000941:Antigens; D001323:Autoantibodies; D001324:Autoantigens; D000939:Epitopes; D007074:Immunoglobulin G; C433683:REXO1L1P protein, human
references: Clin Exp Immunol. 2001 Jun;124(3):429-34
references: 11472404
references: J Viral Hepat. 2007 Jan;14(1):36-40
references: 17212642
references: J Infect Dis. 2004 Jan 1;189(1):7-14
references: 14702147
references: Lancet. 1990 Dec 8;336(8728):1400-3
references: 1701012
references: Lancet. 1991 Jan 5;337(8732):47-8
references: 1670664
references: Lancet. 1992 Feb 1;339(8788):267-9
references: 1346282
references: Autoimmunity. 1991;10(4):269-73
references: 1723001
references: J Hepatol. 1991 Nov;13(3):372-4
references: 1808228
references: J Clin Immunol. 1992 May;12(3):178-84
references: 1383257
references: J Hepatol. 1993 Feb;17(2):253-7
references: 7680364
references: J Med Virol. 1993 Mar;39(3):246-50
references: 7682256
references: J Infect. 1993 May;26(3):287-94
references: 7685043
references: Vox Sang. 1993;65(1):38-41
references: 8395747
references: J Med Virol. 1994 Jan;42(1):66-72
references: 7508490
references: Vox Sang. 1994;66(2):151
references: 7514327
references: Clin Exp Immunol. 1994 Jun;96(3):403-9
references: 7516270
references: Gastroenterology. 1994 Nov;107(5):1443-8
references: 7523227
references: J Hepatol. 1994 Jun;20(6):845
references: 7523485
references: J Infect. 1994 Sep;29(2):147-55
references: 7528759
references: J Clin Microbiol. 1995 Jan;33(1):209-11
references: 7535312
references: J Infect Dis. 1996 Feb;173(2):300-5
references: 8568289
references: J Infect Dis. 1996 Apr;173(4):808-21
references: 8603958
references: J Hepatol. 1996 Jan;24(1):15-20
references: 8834019
references: J Infect Dis. 1997 Jul;176(1):27-33
references: 9207346
references: Hepatology. 1999 Jan;29(1):223-9
references: 9862870
references: Clin Infect Dis. 2005 Mar 15;40(6):e49-54
references: 15736006
references: Lancet Infect Dis. 2005 Apr;5(4):227-36
references: 15792740
references: Gut. 2005 May;54(5):682-5
references: 15831916
references: Hepatology. 2006 Jan;43(1):91-9
references: 16323211
references: Aliment Pharmacol Ther. 2006 Apr 15;23(8):1153-9
references: 16611276
references: J Virol. 2006 Nov;80(22):10972-9
references: 17071928
references: J Clin Microbiol. 2006 Dec;44(12):4559-60
references: 17021056
references: J Clin Pathol. 2002 Jan;55(1):4-13
references: 11825916